REGULATORY

AMED to Strengthen Coordination Between Projects: New President

May 7, 2025

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Japan Agency for Medical Research and Development (AMED) will double down on efforts to boost coordination between different funding projects under its new president Hitoshi Nakagama by modifying how it supports healthcare R&D in the country. Nakagama, who took…

To read the full story

NCC President Nakagama to Lead AMED from April
March 26, 2025
AMED President Mishima Hints at Resignation
March 25, 2025

REGULATORY

LDP Lawmakers Seek Separate Drug Pricing Measures for Inflation
July 2, 2026
Govt’s Honebuto Draft Confirms FY2027 Off-Year Drug Price Revision
July 1, 2026
Govt Presents Growth Strategy Draft Ahead of July Approval
July 1, 2026
Japan Moves to Add Ceftriaxone to Economic Security List
July 1, 2026
LDP Group Submits Honebuto Proposal, Urges Pediatric Cancer Platform
July 1, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…